Should Aspirin Be Added for Coronary Artery Disease on Statin Therapy?
Yes, aspirin 75-100 mg daily should be added to statin therapy for patients with established coronary artery disease and atherosclerosis on CT scan. 1, 2
Guideline-Based Recommendation
The evidence strongly supports aspirin use in your clinical scenario:
Aspirin 75-162 mg daily is a Class I recommendation (highest level) for all patients with coronary artery disease unless contraindicated. 1 This represents the strongest possible guideline recommendation, indicating that benefits substantially outweigh risks in patients with established CAD.
The 2011 AHA/ACCF guidelines explicitly state this applies to patients with atherosclerotic vascular disease, which includes your patient with CAD and atherosclerosis on CT imaging. 1
The preferred maintenance dose is 75-100 mg daily (or 81 mg in the US), which provides maximal cardiovascular protection with lower gastrointestinal toxicity compared to higher doses. 1, 2, 3
Why This Combination Matters
The combination of aspirin plus statin provides additive benefits:
Aspirin reduces thrombotic events (myocardial infarction, stroke) through antiplatelet effects, while statins reduce atherosclerotic progression through lipid-lowering and pleiotropic anti-inflammatory effects. 4, 5
In patients with established CAD, the combination of aspirin, statin, and blood pressure-lowering agents reduces the risk of myocardial infarction by 32% (HR 0.68), stroke by 63% (HR 0.37), and all-cause mortality by 31% (HR 0.69) compared to incomplete therapy. 4
The absolute benefits of aspirin in secondary prevention (36 per 1000 patients over 2 years for those with prior MI) substantially outweigh bleeding risks in patients with established atherosclerotic disease. 6
Critical Bleeding Risk Assessment
Before initiating aspirin, assess for contraindications:
- History of gastrointestinal bleeding or peptic ulcer disease 3
- Concurrent anticoagulation therapy (warfarin, DOACs) 1
- Thrombocytopenia or bleeding disorders 3
- Uncontrolled hypertension 3
- Aspirin allergy (use clopidogrel 75 mg daily as alternative) 1, 2
Gastroprotection Strategy
For patients at increased GI bleeding risk who require aspirin:
Concomitant proton pump inhibitor therapy is recommended for those with history of GI bleeding, age >70 years, concurrent NSAID use, or high alcohol consumption. 2, 3
The lowest effective aspirin dose (75-100 mg daily) minimizes GI toxicity while maintaining cardiovascular efficacy. 6
Common Pitfalls to Avoid
Do not use higher aspirin doses (>100 mg daily) for chronic maintenance therapy - they increase bleeding risk without additional cardiovascular benefit. 1, 2
Do not add dual antiplatelet therapy (aspirin + clopidogrel) in stable CAD unless the patient has had recent acute coronary syndrome or stent placement within the past 12 months. 1, 2 Dual therapy beyond 12 months increases bleeding risk without additional benefit.
Do not withhold aspirin due to concerns about "aspirin resistance" - no platelet function testing is recommended to guide aspirin therapy in individual patients. 6
Avoid NSAIDs in patients on aspirin - ibuprofen can block aspirin's access to COX-1, potentially reducing its effectiveness. 6, 2 If NSAIDs are necessary, consider selective COX-2 inhibitors.
Special Population: Chronic Kidney Disease
If your patient has CKD, the recommendation remains valid but requires closer monitoring:
Aspirin is recommended for secondary prevention in CKD patients with established CAD (Class C recommendation from KDIGO 2024). 7
The relative risk reduction for MI is 12% in CKD patients, though bleeding risk is elevated (35% relative increase in major bleeding). 7
The benefits for secondary prevention still outweigh risks in most CKD patients with established CAD, but monitor more closely for bleeding complications. 7
Alternative if Aspirin Cannot Be Used
If aspirin is contraindicated or not tolerated, clopidogrel 75 mg daily is the recommended alternative - it provides equivalent cardiovascular protection. 1, 2, 3